|
By Petra Maertens, Director and Chantal Savelkouls, Director
Once again this year’s American Society of Clinical Oncology (ASCO) annual meeting was a busy and well-attended congress. For those of us seasoned ASCO veterans who have been attending for numerous years, as the GfK Oncology team has, we are used to the sheer size of this conference and the wealth of information presented.
Therefore it is always interesting when we talk to those attending for the first time. As one of them commented to us: “It is bewildering fighting your way through the information jungle, there is so much data being presented. Where do I go first?”
So what was the interesting data coming out of ASCO this year?
|